Cargando…
Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
BACKGROUND: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low ris...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215886/ https://www.ncbi.nlm.nih.gov/pubmed/25360819 http://dx.doi.org/10.1371/journal.pone.0110228 |
_version_ | 1782342170147028992 |
---|---|
author | Omosa-Manyonyi, Gloria Park, Harriet Mutua, Gaudensia Farah, Bashir Bergin, Philip J. Laufer, Dagna Lehrman, Jennifer Chinyenze, Kundai Barin, Burc Fast, Pat Gilmour, Jill Anzala, Omu |
author_facet | Omosa-Manyonyi, Gloria Park, Harriet Mutua, Gaudensia Farah, Bashir Bergin, Philip J. Laufer, Dagna Lehrman, Jennifer Chinyenze, Kundai Barin, Burc Fast, Pat Gilmour, Jill Anzala, Omu |
author_sort | Omosa-Manyonyi, Gloria |
collection | PubMed |
description | BACKGROUND: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low risk of HIV and other sexually transmitted infections. METHODS AND FINDINGS: The Kenya AIDS Vaccine Initiative (KAVI) enrolled participants into three Phase 1 trials of preventive HIV candidate vaccines in 2011–2012 at two clinical research centers in Nairobi. After informed consent to a mucosal sub-study, participants were asked to undergo collection of mucosal secretions (saliva, oral fluids, semen, cervico-vaginal and rectal), but could opt out of any collection at any visit. Specimens were collected at baseline and two additional time points. A tolerability questionnaire was administered at the final sub-study visit. Of 105 trial participants, 27 of 34 women (79%) and 62 of 71 men (87%) enrolled in the mucosal sub-study. Nearly all sub-study participants gave saliva and oral fluids at all visits. Semen was collected from about half the participating men (47–48%) at all visits. Cervico-vaginal secretions were collected by Softcup from about two thirds of women (63%) at baseline, increasing to 78% at the following visits, with similar numbers for cervical secretion collection by Merocel sponge; about half of women (52%) gave cervico-vaginal samples at all visits. Rectal secretions were collected with Merocel sponge from about a quarter of both men and women (24%) at all 3 visits, with 16% of men and 19% of women giving rectal samples at all visits. CONCLUSIONS: Repeated mucosal sampling in clinical trial participants in Kenya is feasible, with a good proportion of participants consenting to most sampling methods with the exception of rectal samples. Experienced staff members of both sexes and trained counselors with standardized messaging may improve acceptance of rectal sampling. |
format | Online Article Text |
id | pubmed-4215886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42158862014-11-05 Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya Omosa-Manyonyi, Gloria Park, Harriet Mutua, Gaudensia Farah, Bashir Bergin, Philip J. Laufer, Dagna Lehrman, Jennifer Chinyenze, Kundai Barin, Burc Fast, Pat Gilmour, Jill Anzala, Omu PLoS One Research Article BACKGROUND: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low risk of HIV and other sexually transmitted infections. METHODS AND FINDINGS: The Kenya AIDS Vaccine Initiative (KAVI) enrolled participants into three Phase 1 trials of preventive HIV candidate vaccines in 2011–2012 at two clinical research centers in Nairobi. After informed consent to a mucosal sub-study, participants were asked to undergo collection of mucosal secretions (saliva, oral fluids, semen, cervico-vaginal and rectal), but could opt out of any collection at any visit. Specimens were collected at baseline and two additional time points. A tolerability questionnaire was administered at the final sub-study visit. Of 105 trial participants, 27 of 34 women (79%) and 62 of 71 men (87%) enrolled in the mucosal sub-study. Nearly all sub-study participants gave saliva and oral fluids at all visits. Semen was collected from about half the participating men (47–48%) at all visits. Cervico-vaginal secretions were collected by Softcup from about two thirds of women (63%) at baseline, increasing to 78% at the following visits, with similar numbers for cervical secretion collection by Merocel sponge; about half of women (52%) gave cervico-vaginal samples at all visits. Rectal secretions were collected with Merocel sponge from about a quarter of both men and women (24%) at all 3 visits, with 16% of men and 19% of women giving rectal samples at all visits. CONCLUSIONS: Repeated mucosal sampling in clinical trial participants in Kenya is feasible, with a good proportion of participants consenting to most sampling methods with the exception of rectal samples. Experienced staff members of both sexes and trained counselors with standardized messaging may improve acceptance of rectal sampling. Public Library of Science 2014-10-31 /pmc/articles/PMC4215886/ /pubmed/25360819 http://dx.doi.org/10.1371/journal.pone.0110228 Text en © 2014 Omosa-Manyonyi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Omosa-Manyonyi, Gloria Park, Harriet Mutua, Gaudensia Farah, Bashir Bergin, Philip J. Laufer, Dagna Lehrman, Jennifer Chinyenze, Kundai Barin, Burc Fast, Pat Gilmour, Jill Anzala, Omu Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya |
title | Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya |
title_full | Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya |
title_fullStr | Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya |
title_full_unstemmed | Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya |
title_short | Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya |
title_sort | acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in kenya |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215886/ https://www.ncbi.nlm.nih.gov/pubmed/25360819 http://dx.doi.org/10.1371/journal.pone.0110228 |
work_keys_str_mv | AT omosamanyonyigloria acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT parkharriet acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT mutuagaudensia acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT farahbashir acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT berginphilipj acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT lauferdagna acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT lehrmanjennifer acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT chinyenzekundai acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT barinburc acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT fastpat acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT gilmourjill acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya AT anzalaomu acceptabilityandfeasibilityofrepeatedmucosalspecimencollectioninclinicaltrialparticipantsinkenya |